Table 1:
Summary of clinical information
| Case | Age | Initial Diagnosis | Stage | Clinical Follow-up (from time of initial diagnosis) |
|---|---|---|---|---|
| 1 | 27 | SBT with HGSC | I | - Lost to follow-up |
| 2 | 33 | SBT | I | - IGSC, peritoneal rec. (25 years) - Lost to follow-up |
| 3 | 59 | LGSC | III | - High grade Mullerian ca., pelvic lymph node rec. (44 months) - Died (74 months) |
| 4 | 55 | SBT with HGSC | IV | - HGSC, abdominal wall rec. (8 months), - Alive with disease (40 months) |
| 5 | 35 | miSBT (ovary) with IGSC (diaphragm) | IV | - HGSC, axillary lymph node rec. (33 months) - Died (49 months) |
| 6 | 35 | miSBT with LGSC | III | - IGSC (55 months), peritoneal rec. - LGSC, chest wall rec. (78 months) - Alive with disease (11 years) |
| 7 | 70 | SBT with LGSC | IV | - Undifferentiated sarcomatoid ca. rec. (37 months) - Died (37 months) |
Abbreviations: HGSC – high-grade serous carcinoma; IGSC – indeterminate-grade serous carcinoma; LGSC – low-grade serous carcinoma; miSBT – micropapillary serous borderline tumor; rec – recurrence; SBT – serous borderline tumor